BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25193342)

  • 1. Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer.
    Vasudevan A; Yu Y; Banerjee S; Woods J; Farhana L; Rajendra SG; Patel A; Dyson G; Levi E; Maddipati KR; Majumdar AP; Nangia-Makker P
    Cancer Prev Res (Phila); 2014 Nov; 7(11):1138-48. PubMed ID: 25193342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin: a potential therapeutic agent for recurrent colon cancer.
    Nangia-Makker P; Yu Y; Vasudevan A; Farhana L; Rajendra SG; Levi E; Majumdar AP
    PLoS One; 2014; 9(1):e84369. PubMed ID: 24465408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.
    Yu Y; Sarkar FH; Majumdar AP
    Transl Oncol; 2013 Apr; 6(2):180-6. PubMed ID: 23544170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy.
    De Carlo F; Witte TR; Hardman WE; Claudio PP
    PLoS One; 2013; 8(7):e69760. PubMed ID: 23874993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
    Yu Y; Nangia-Makker P; Farhana L; G Rajendra S; Levi E; Majumdar AP
    Mol Cancer; 2015 May; 14():98. PubMed ID: 25928322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells.
    Genovese S; Epifano F; Preziuso F; Slater J; Nangia-Makker P; Majumdar APN; Fiorito S
    Biochem Biophys Res Commun; 2020 Jan; 522(1):95-99. PubMed ID: 31740005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
    Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
    Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
    Lim K; Han C; Dai Y; Shen M; Wu T
    Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status.
    Gaur S; Chen L; Ann V; Lin WC; Wang Y; Chang VH; Hsu NY; Shia HS; Yen Y
    Mol Cancer; 2014 Feb; 13():21. PubMed ID: 24495750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21.
    Roy S; Yu Y; Padhye SB; Sarkar FH; Majumdar AP
    PLoS One; 2013; 8(7):e68543. PubMed ID: 23894315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antrodia cinnamomea Enhances Chemo-Sensitivity of 5-FU and Suppresses Colon Tumorigenesis and Cancer Stemness via Up-Regulation of Tumor Suppressor miR-142-3p.
    Huang YJ; Yadav VK; Srivastava P; Wu AT; Huynh TT; Wei PL; Huang CF; Huang TH
    Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31349708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Omegaven®, EPA, DHA and oxaliplatin on oesophageal adenocarcinoma cell lines growth, cytokine and cell signal biomarkers expression.
    Eltweri AM; Howells LM; Thomas AL; Dennison AR; Bowrey DJ
    Lipids Health Dis; 2018 Jan; 17(1):19. PubMed ID: 29378575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.
    Piazzi G; D'Argenio G; Prossomariti A; Lembo V; Mazzone G; Candela M; Biagi E; Brigidi P; Vitaglione P; Fogliano V; D'Angelo L; Fazio C; Munarini A; Belluzzi A; Ceccarelli C; Chieco P; Balbi T; Loadman PM; Hull MA; Romano M; Bazzoli F; Ricciardiello L
    Int J Cancer; 2014 Nov; 135(9):2004-13. PubMed ID: 24676631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.
    Prabhu VV; Allen JE; Dicker DT; El-Deiry WS
    Cancer Res; 2015 Apr; 75(7):1423-32. PubMed ID: 25712124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Su P; Yang Y; Wang G; Chen X; Ju Y
    Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ME-143 Is Superior to Genistein in Suppression of WNT Signaling in Colon Cancer Cells.
    Pintova S; Planutis K; Planutiene M; Holcombe RF
    Anticancer Res; 2017 Apr; 37(4):1647-1653. PubMed ID: 28373425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
    Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of β-catenin in colon cancer stem cells.
    Panda PK; Naik PP; Praharaj PP; Meher BR; Gupta PK; Verma RS; Maiti TK; Shanmugam MK; Chinnathambi A; Alharbi SA; Sethi G; Agarwal R; Bhutia SK
    Mol Carcinog; 2018 May; 57(5):664-677. PubMed ID: 29457276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis.
    Shen W; Zhang X; Tang J; Zhang Z; Du R; Luo D; Liu X; Xia Y; Li Y; Wang S; Yan S; Yang W; Xiang R; Luo N; Luo Y; Li J
    Theranostics; 2021; 11(5):2297-2317. PubMed ID: 33500726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.